OneMain vs. Upstart: Which Consumer Loan Stock Is a Better Buy in 2026?

The article compares OneMain, a traditional branch-based nonprime lender, with Upstart, an AI-driven lending marketplace. OneMain offers steady profitability with $6.2B revenue and 12.5% net margin but faces risks from macroeconomic downturns affecting its subprime borrower base. Upstart shows explosive 59% revenue growth and returned to profitability but carries concentration risk with three partners originating 83% of loans. The author recommends Upstart for 2026 based on superior growth prospects (36% expected revenue increase vs. OneMain's 10%) and a higher-quality customer base, despite its higher valuation.

06/17/2026, 11:15 AM • The Motley Fool

Dan Loeb Calls Selling Palantir In The $20s A 'Huge Mistake:' 'I Missed A 10X'

Third Point CEO Dan Loeb admitted to prematurely selling Palantir Technologies shares in the $20 range before its IPO, missing out on a 10x return as the stock rallied significantly post-public listing. Loeb also reflected on broader challenges in managing high-growth tech investments and the constraints of public market liquidity, citing his firm's experience with Upstart as a cautionary tale about board restrictions limiting trading flexibility.

06/12/2026, 2:29 AM • Benzinga

UPST IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Upstart Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action – UPST

A securities class action lawsuit has been filed against Upstart Holdings, Inc. alleging that the company made false and misleading statements about its Model 22 AI risk assessment tool. The lawsuit claims the model frequently overreacted to negative economic signals, overstating accuracy and loan approval rates, which negatively impacted revenue and made 2025 guidance unreliable. Investors who purchased UPST securities between May 14, 2025 and November 4, 2025 may be eligible for compensation. The lead plaintiff deadline is June 8, 2026.

06/05/2026, 5:20 PM • GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VERI

Rosen Law Firm is urging investors who purchased Veritone, Inc. securities between October 14, 2025 and April 14, 2026 to join a class action lawsuit before the July 20, 2026 lead plaintiff deadline. The lawsuit alleges that Veritone made false statements about its financial performance, inaccurately recorded revenue and costs, overstated assets, and maintained deficient internal controls, leading to required financial statement restatements.

06/04/2026, 8:46 PM • GlobeNewswire

UPST DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Upstart Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action – UPST

Rosen Law Firm is reminding investors in Upstart Holdings who purchased securities between May 14, 2025 and November 4, 2025 of an important June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Upstart made false and misleading statements regarding its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative economic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 guidance unreliable.

06/04/2026, 7:44 PM • GlobeNewswire

MEDPACE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - MEDP

Rosen Law Firm is notifying investors in Medpace Holdings, Upstart Holdings, and Babcock & Wilcox Enterprises of securities class action lawsuits. The firm alleges that Medpace made false statements about backlog cancellation rates and provided misleading growth projections. Investors with losses exceeding $100,000 are encouraged to secure counsel before the June 8, 2026 deadline to potentially serve as lead plaintiffs.

06/04/2026, 7:18 PM • GlobeNewswire

Upstart's Biggest Risk Isn't Its AI Models. It's Who Funds the Loans.

Upstart Holdings announced plans to apply for a national bank charter to reduce its reliance on third-party lenders for loan funding. While the company showed strong Q1 growth with 61% year-over-year loan origination growth and 44% revenue increase, it remains unprofitable with rising expenses. The stock has risen 18% since the March bank charter announcement but is still down 26% year-to-date.

06/04/2026, 4:05 PM • The Motley Fool

Bronstein, Gewirtz & Grossman LLC Urges Upstart Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Upstart Holdings, Inc. alleging that the company made false and misleading statements about its Model 22 AI underwriting model. The complaint claims the model frequently overreacted to negative macroeconomic signals, overstating its accuracy and approval rates, and negatively impacting revenue results. The lawsuit covers investors who purchased Upstart securities between May 14, 2025 and November 4, 2025.

06/04/2026, 12:00 PM • GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Upstart Holdings, Inc. and Certain Officers – UPST

A class action lawsuit has been filed against Upstart Holdings for alleged securities fraud. The complaint alleges that defendants made false statements about Model 22's accuracy and loan approval rates. The truth emerged on November 4, 2025, when Upstart reported Q3 revenue of $277 million, missing guidance, and revealed that Model 22 had overreacted to macroeconomic signals, reducing approvals. The stock fell 9.71% following the disclosure.

06/02/2026, 3:55 PM • GlobeNewswire

UPST Investor Alert: Upstart Holdings Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Inflated AI Projections: Levi & Korsinsky

Upstart Holdings faces a securities class action lawsuit after allegedly inflating AI model performance projections. The company's flagship AI underwriting model suppressed loan approvals in Q3 2025, leading to a $4.49 per share (9.71%) decline and a $44 million revenue guidance cut. Institutional investors who purchased shares between May 14, 2025 and November 4, 2025 may seek lead plaintiff status by the June 8, 2026 deadline.

06/01/2026, 2:57 PM • GlobeNewswire

GOSS DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action – GOSS

Rosen Law Firm has issued deadline notices for securities class action lawsuits against Gossamer Bio, Upstart Holdings, and POET Technologies. Investors with losses exceeding $100K are encouraged to secure counsel before upcoming deadlines. The lawsuits allege false and misleading statements regarding clinical trial design and other material facts.

05/30/2026, 6:52 PM • GlobeNewswire

UPST DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Upstart Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action – UPST

Rosen Law Firm is notifying investors in Upstart Holdings, Inc. (NASDAQ: UPST) of a June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Upstart made false and misleading statements regarding its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative macroeconomic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 revenue guidance unreliable.

05/30/2026, 5:25 PM • GlobeNewswire

UPST DEADLINE: The Gross Law Firm Reminds Upstart, Inc. Investors of Upcoming Securities Class Action Deadline

A securities class action lawsuit has been filed against Upstart, Inc. alleging that the company issued materially false and misleading statements regarding its AI Model 22. The complaint claims the model frequently overreacted to negative macroeconomic signals, leading to overstated accuracy claims and overly conservative credit assessments that negatively impacted revenue. The deadline for lead plaintiff registration is June 8, 2026.

05/29/2026, 9:00 AM • GlobeNewswire

Upstart vs. Pagaya Technologies: Which Financial Stock Is a Better Buy in 2026?

Upstart and Pagaya Technologies both use AI to revolutionize lending by replacing traditional credit scores. Upstart generated $1.1B in revenue with $53.6M net income but faces risks from high customer concentration and negative free cash flow of -$166.1M. Pagaya achieved $1.3B revenue with $81.4M net income and positive free cash flow of $224.7M, trading at lower valuations. For long-term investors, Pagaya appears to offer a more balanced opportunity due to its superior financial health and less direct exposure to borrower defaults.

05/28/2026, 2:18 PM • The Motley Fool

Upstart's Auto Loan Push Is the 1 Story That Could Change the AI Lending Thesis

Upstart Holdings is expanding beyond its core unsecured personal loan business into auto loans and mortgages, with Q1 auto loan originations quadrupling year-over-year to $263 million and mortgage originations reaching $143 million. While these segments remain small compared to the $3 billion in personal loans, they represent significant growth opportunities given the massive size of the auto loan ($1.7 trillion) and mortgage ($18.8 trillion) markets. The company has originated only 12,202 car loans and 2,300 home loans versus 410,854 personal loans, indicating substantial room for market penetration.

05/28/2026, 2:11 PM • The Motley Fool